- Home
- CRGY vs CNTA Comparison
CRGY vs CNTA Comparison
Compare CRGY & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGY
- CNTA
- Stock Information
- Founded
- CRGY 1986
- CNTA 2020
- Country
- CRGY United States
- CNTA United Kingdom
- Employees
- CRGY N/A
- CNTA N/A
- Industry
- CRGY Oil & Gas Production
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- CRGY Energy
- CNTA Health Care
- Exchange
- CRGY Nasdaq
- CNTA Nasdaq
- Market Cap
- CRGY 2.2B
- CNTA 1.9B
- IPO Year
- CRGY N/A
- CNTA 2021
- Fundamental
- Price
- CRGY $8.93
- CNTA $16.81
- Analyst Decision
- CRGY Buy
- CNTA Strong Buy
- Analyst Count
- CRGY 11
- CNTA 11
- Target Price
- CRGY $16.50
- CNTA $28.90
- AVG Volume (30 Days)
- CRGY 2.8M
- CNTA 1.1M
- Earning Date
- CRGY 08-04-2025
- CNTA 08-12-2025
- Dividend Yield
- CRGY 5.40%
- CNTA N/A
- EPS Growth
- CRGY N/A
- CNTA N/A
- EPS
- CRGY N/A
- CNTA N/A
- Revenue
- CRGY $3,223,618,000.00
- CNTA $15,000,000.00
- Revenue This Year
- CRGY $27.16
- CNTA N/A
- Revenue Next Year
- CRGY N/A
- CNTA N/A
- P/E Ratio
- CRGY N/A
- CNTA N/A
- Revenue Growth
- CRGY 31.58
- CNTA 118.88
- 52 Week Low
- CRGY $6.83
- CNTA $9.10
- 52 Week High
- CRGY $16.94
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- CRGY 48.22
- CNTA 67.45
- Support Level
- CRGY $8.42
- CNTA $15.05
- Resistance Level
- CRGY $9.69
- CNTA $17.69
- Average True Range (ATR)
- CRGY 0.35
- CNTA 0.77
- MACD
- CRGY 0.05
- CNTA 0.08
- Stochastic Oscillator
- CRGY 53.94
- CNTA 70.10
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.